Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of Unilateral 6-hydroxydopamine induced Parkinson's rats: Effect of 5-HT, GABA and bone marrow cell supplementation

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Nandhu, Ms ^a   Paul, Jes ^a   Kuruvilla, Korah P ^a   Malat, Anitha ^a   Romeo, Chinthu ^a   Paulose, C S ^a  

^a Department of Physics   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA SYNUCLEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; INOSITOL TRISPHOSPHATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OXIDOPAMINE; PROTEIN BAX; SEROTONIN; UBIQUITIN THIOLESTERASE; CYCLIC AMP; INOSITOL PHOSPHATE; INOSITOL TRISPYROPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BINDING AFFINITY; BONE MARROW TRANSPLANTATION; BRAIN CORTEX; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG PROTEIN BINDING; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; UPREGULATION; ALLOTRANSPLANTATION; ANIMAL; ANIMAL BEHAVIOR; BONE MARROW CELL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; METABOLISM; PATHOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; BEHAVIOR, ANIMAL; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CEREBRAL CORTEX; CYCLIC AMP; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; INOSITOL PHOSPHATES; MALE; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, WISTAR; SEROTONIN; SUBSTANTIA NIGRA; TRANSPLANTATION, HOMOLOGOUS;

EID: 79251566459     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-5     Document Type: Article

References (51)

1. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and parkinsonian brains. Y Smith R Villalba, Mov Disord 2008 23 534 S547 10.1002/mds.22027 18781680
2. Lesions outside the CNS in Parkinson's disease. R Djaldetti N Lev E Melamed, Mov Disord 2009 24 793 800 10.1002/mds.22172 19224610
3. Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects. I Ferrer, Prog Neurobiol 2009 88 2 89 103 10.1016/j.pneurobio.2009.02.004 19482226
4. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. JP Lefaucheur, Clin Neurophysiol 2005 116 2 244 53 10.1016/j.clinph.2004.11.017 15661100
5. From the cell to the clinic: A comparative reviewof the partial D2/D3 receptor agonist and 2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease. MJ Millan, Pharmacology & Therapeutics 2010 128 229 73
6. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. T Alexi CV Borlongan RL Faull CE Williams RG Clark PD Gluckman PE Hughes, Prog Neurobiol 2000 60 5 409 70 10.1016/S0301-0082(99) 00032-5 10697073
7. Glutamate receptor function in learning and memory. G Riedel B Platt J Micheau, Behav Brain Res 2003 140 1 47 10.1016/S0166-4328(02)00272-3 12644276
8. Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain. VL Rao KK Bowen RJ Dempsey, Neurochem Res 2001 26 497 502 10.1023/A:1010956711295 11513475
9. Purification and characterization of a neurite extension factor from bovine brain. D Kligman DR Marshak, Proc Natl Acad Sci USA 1985 82 7136 7139 10.1073/pnas.82.20.7136 3863143
10. Serotonin as a differentiation signal in early neurogenesis. JM Lauder H Krebs, Dev Neurosci 1978 1 15 30 10.1159/000112549 158519
11. Serotonin as a neurotrophic factor in the fetal brain: Binding, capture and release in centers of axonal growth. J Rodriguez Hernandez, Gac Med Mex 1994 130 246 252 8964332
12. GABA receptor antagonist modulate postmitotic cell migration in slice culture of embryonic rat cortex. TN Behar AE Schaffner CA Scott CL Green JL Barker, Cereb Cortex 2000 10 899 909 10.1093/cercor/10.9.899 10982750
13. Differential modulation of proliferation in the neocortical venrticular and subventricular zone. TF Haydar F Wang ML Schwartz P Rakic, J Neurosci 2000 20 15 5764 5774 10908617
14. GABA stimulates chemotaxis and chemokinesis of embryonic cortical neurons via calcium dependent mechanism. TN Behar Y Li HT Tarn W Ma V Dunlap C Scott JL Barker, J Neurosci 1996 16 5 1808 1818 8774448
15. Cell proliferation in response to GABA in postnatal hippocampal slice culture. G Ben-Yaakov H Golan, Int J Dev Neurosci 2003 21 3 153 7 10.1016/S0736-5748(03)00027-3 12711353
16. Induction of DNA synthesis in primary culture of rat hepatocyte by serotonin: possible involvement of serotonin S2 receptor. B Sudha CS Paulose, Hepatology 1998 27 62 66 10.1002/hep.510270111 9425918
17. Areceptor functional regulation during liver cell proliferation. MP Biju S Pyroja KNV Rajesh CS Paulose, Hepatol Res 2001 21 136 146 10.1016/S1386-6346(01)00092-4 11551834 (Pubitemid 32899084)
18. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. U Ungerstedt, Acta Physiol Scand Suppl 1971 367 95 122 4332694
19. 3H] dopa in various regions of the brain. J Glowinski LL Iversen, J Neurochem 1966 13 655 669 10.1111/j.1471-4159.1966.tb09873.x 5950056
20. Sympathetic stimulation and hypertension in pyridoxine deficint adult rat. CS Paulose K Dakshinamurti S Packer NL Stephens, Hypertension 1988 11 387 391 3356457
21. A simple, sensitive and specific radioreceptor assay for endogenous GABA in brain tissue. SJ Enna SH Snyder, J Neurochem 1976 26 221 224 10.1111/j.1471-4159.1976.tb04465.x 1255176
22. 3H] glutamate binding sites in the rat central nervous system. JG Timothy AB Young JB Penny, J Neurosci 1984 4 2133 2144 6088729
23. The in vivo effect of bilirubin on the N-methyl-D-aspartate receptor/ion channel complex in the brains of newborn piglets. DJ Hoffman SA Zanelli JM Kubin P Om PM Delivoria, Pediatr Res 1996 40 804 808 10.1203/00006450-199612000-00005 8947954
24. Protein measurement with folin Phenol reagent. OH Lowry NH Rosenbrough AL Farr RJ Randall, J Biol Chem 1951 193 265 75 14907713
25. The attractions of proteins for small molecules and ions. G Scatchard, Ann New York Ac Sci 1949 51 4 660 672 10.1111/j.1749-6632.1949.tb27297.x
26. Preferential neuron loss in rat piriform cortex following pilocarpine induced status epilepticus. S Chen M Kobayashi Y Honda S Kakuta F Sato K Kishi, Epilepsy Res 2007 74 1 18 10.1016/j.eplepsyres.2006.11.008 17194568
27. Metabolic effects of nigrostriatal denervation in basal ganglia. EC Hirsch C Perier G Orieux C Francois J Feger J Yelnik M Vila R Levy ES Tolosa C Marin M Herrero Trinidad JA Obeso Y Agid, Trends Neurosci 2000 23 78 85 10.1016/S1471-1931(00)00021-5 11052224
28. A comparison of cerebral glucose metabolism in Parkinson's disease. Parkinson's disease dementia and dementia with Lewy bodies. SW Yong JK Yoon YS An PH Lee, Eur J Neurol 2007 14 1357 1362 10.1111/j.1468-1331.2007.01977.x 17941855
29. Changes in network activity with the progression of Parkinson's disease. C Huang C Tang A Feigin M Lesser Y Ma M Pourfar V Dhawan D Eidelberg, Brain 2007 130 1834 1846 10.1093/brain/awm086 17470495 (Pubitemid 47343798)
30. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. C Huang P Mattis K Perrine N Brown V Dhawan D Eidelberg, Neurology 2008 70 1470 1477 10.1212/01.wnl.0000304050.05332.9c 18367705
31. Complex I deficiency in Parkinson's disease frontal cortex. WD Parker JK Parks RH Swerdlow, Brain Res 2008 1189 215 218 10.1016/j.brainres.2007.10.061 18061150
32. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease. I Ferrer E Perez E Dalfá M Barrachina, Neurosci Lett 2007 415 3 205 9 10.1016/j.neulet.2007.01.026 17284347
33. Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation. H Gurden JP Tassin TM Jay, Neuroscience 1999 94 1019 1027 10.1016/S0306-4522(99)00395-4 10625044
34. Appetitive instrumental learning requires coincident activation of NMDA and dopamine D1 receptors within the medial prefrontal cortex. AE Baldwin K Sadeghian AE Kelley, J Neurosci 2002 22 1063 1071 11826135
35. Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction. H Katagiri K Tanaka T Manabe, Eur J Neurosci 2001 14 547 553 10.1046/j.0953-816x.2001.01664.x 11553304
36. Transcriptional regulation through glutamate receptors: Involvement of tyrosine kinases. E Lápez-Bayghen A Aguirre A Ortega, J Neurosci Res 2003 74 5 717 25 14635222
37. Inositol trisphosphate and diacylglycerol: two interacting second messengers. MJ Berridge, Annu Rev Biochem 1987 56 159 193 3304132
38. 2+) sensors, NCS-1 and PICK1. J Jo S Heon MJ Kim GH Son Y Park JM Henley JL Weiss M Sheng GL Collingridge K Cho, Neuron 2008 60 1095 1111 10.1016/j.neuron.2008.10.050 19109914
39. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons. M Hara R Fukui E Hieda M Kuroiwa HS Bateup T Kano P Greengard A Nishi, J Neurochem 2010 113 4 1046 59 10.1111/j.1471-4159.2010. 06668.x 20236221
40. Regulation of cell death: the calcium-apoptosis link. S Orrenius B Zhivotovsky P Nicotera, Nat Rev Mol Cell Biol 2003 4 552 565 10.1038/nrm1150 12838338
41. Regulation of neuronal cell death and neurodegeneration by members of the bcl-2 family: therapeutic implications. JJ Shacka KA Roth, Curr Drug Targets CNS Neurol Disord 2005 4 25 39 10.2174/1568007053005127 15723611
42. CREB couples neurotrophin signals to survival messages. S Finkbeiner, Neuron 2000 25 11 14 10.1016/S0896-6273(00)80866-1 10707967
43. Transcriptional regulation by the phosphorylation-dependent factor CREB. B Mayr M Montminy, Nat Rev Mol Cell Biol 2001 2 599 609 10.1038/35085068 11483993
44. Functional repression of cAMP response element in 6-hydroxydopamine- treated neuronal cells. EM Chalovich JH Zhu J Caltagarone R Bowser CT Chu, J Biol Chem 2006 281 26 17870 81 10.1074/jbc.M602632200 16621793
45. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. K Arima K Uéda N Sunohara S Hirai Y Izumiyama H Tonozuka-Uehara M Kawai, Brain Res 1998 808 1 93 100 10.1016/S0006-8993(98) 00734-3 9795161
46. Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death. B Monti E Polazzi L Batti C Crochemore M Virgili A Contestabile, J Neurochem 2007 103 2 518 30 10.1111/j.1471-4159.2007. 04778.x 17635667
47. Increased Levels of Ubiquitin in the 6-OHDA-Lesioned Striatum of Rats. P Johan S Per MC Richard EA Per, J Proteome Res 2005 4 2 223 226 10.1021/pr049836h 15822896
48. Multilineage potential of adult human mesenchymal stem cells. MF Pittenger AM Mackay SC Beck RK Jaiswal R Douglas JD Mosca MA Moorman DW Simonetti S Craig DR Marshak, Science 1999 284 143 147 10.1126/science.284.5411. 143 10102814
49. Adult bone marrow stromal cells differentiate into neural cells in vitro. J Sanchez-Ramos S Song F Cardozo-Pelaez C Hazzi T Stedeford A Willing TB Freeman S Saporta W Janssen N Patel DR Cooper PR Sanberg, Exp Neurol 2000 164 247 256 10.1006/exnr.2000.7389 10915564
50. Adult rat and human bone marrow stromal cells differentiate into neurons. D Woodbury EJ Schwarz DJ Prockop IB Black, J Neurosci Res 2000 61 364 370 10.1002/1097-4547(20000815)61:4<364::AID-JNR23.0.CO;2-C 10931522
51. Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease. M McCollum Z Ma E Cohen R Leon R Tao JY Wu D Maharaj J Wei, Mol Neurobiol 2010 41 2-3 410 9 10.1007/s12035-010-8118-4 20405343